BioMelbourne Network
Progressing BioIndustry

News and Opinions

Previous1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9

2014

November

Global Kinetics Corporation Achieves Key Milestones for Expansion

6 November 2014.  Swedish regulatory affairs veteran and former head of European Medicine Agency to join Global Kinetics Board Key EU patent granted covering lead Parkinson’s KinetiGraph™ (PKG™) technology Aggressive expansion agenda for leading mobile health technology company Australian mobile health technology company Global Kinetics Corporation announced today that it has appointed... read more…

Completion of Rights Issue

6 November 2014.  MELBOURNE, Australia: Circadian Technologies Limited (ASX:CIR, OTCQX:CKDXY)  is pleased to confirm the completion  of  the  two for five  fully underwritten  non- renounceable rights issue (Rights Issue) announced on 6 October 2014.The Rights Issue offered up to 19,453,313 new shares at $0.175 per share to eligible shareholders. Eligible shareholders were those with a register... read more…

Victoria election 2014: Labor pledges $60m contribution for biomedical research centre

2 November 2014. The Victorian Labor Party says it will contribute $60 million to Australia's first research and education centre for biomedical engineering if it wins the November 29 state election.Opposition Leader Daniel Andrews said the investment in the Aikenhead Centre for Medical Discovery at St Vincent's Hospital would bring together doctors, scientists and researchers to help Victoria ... read more…
October

Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane® to be PBS Listed for Metastatic Pancreatic Cancer

31 October 2014. • ABRAXANE plus gemcitabine to be PBS listed for Australian patients with metastatic pancreatic cancer from 1 November • ABRAXANE plus gemcitabine significantly improves survival outcomes • A new standard of care now available for all patients with metastatic pancreatic cancer Australian biopharmaceutical company Specialised Therapeutics Australia (STA) is pleased to announ... read more…

Accelerating commercialisation outcomes in Australia

31 October 2014.  Australian businesses and innovators will have access to the full suite of support streams to usher in a new wave of competitiveness and productivity growth under the Australian Government’s $484.2 million Entrepreneurs’ Infrastructure Programme.Minister for Industry Ian Macfarlane today launched the final part of the package, the Accelerating Commercialisation stream, which i... read more…

New $200 million Biotechnology Venture Capital Fund secured in Melbourne

31 October 2014.  Minister for Technology Gordon Rich-Phillips today announced the establishment of the $200 million Biotechnology Translation Fund in conjunction with fund manager Brandon Capital Partners, the manager of the Medical Research Commercialisation Fund (MRCF).Minister Rich-Phillips said the Victorian Coalition Government has secured the fund's headquarters for Melbourne with a cont... read more…

d3 Medicine welcomes a new Director - Dr. Julie Bullock PharmD

30 October 2014.   Dr. Bullock has over 10 years of drug development experience within the FDA. Dr Bullock's pastappointments include Clinical Pharmacology Team Leader and Senior Clinical PharmacologyReviewer. Her regulatory experience was focused in the therapeutic areas of hematology/oncologyand coagulation. She has significant experience in facilitating pediatric drug development,streamlini... read more…

2014 Prime Minister's Prizes for Science

29 October 2014. Joint release with the Hon. Tony Abott MP, Prime Minister Tonight, we recognise and celebrate the accomplishments of Australian science and Australian scientists. Australia has a proud history in science and a wealth of scientific talent. Our people are full of great ideas. The Commonwealth Government will continue to provide the strong support that science needs to find th... read more…

Paving the road ahead for manufacturing in Australia

28 October 2014.  A forum on the future of Australia’s manufacturing sector will bring leaders of industry and academia together to debate the challenges that lie ahead and the role of innovation. The forum is one of the many events planned for Convention 2014 – Australia’s largest ever engineering event which is being organised by peak professional body, Engineers Australia (Melbourne, Nov 24 ... read more…

Join the team at the BioMelbourne Network

27 October 2014.  A fantastic new opportunity has come up as the Membership Engagement Manager at the BioMelbourne Network, the industry association for the biotechnology and medical technology industries of Victoria. Working closely with the Chief Executive Officer, you will design and implement the events programs that engage and serve the BioMelbourne Network membership and the wider life sc... read more…